alnylam pharmaceuticals inc
(ALNY:Consolidated Issue Listed on NASDAQ Global Select )
Laurence E. Reid Ph.D.
Chief Business Officer and Senior Vice President, Alnylam Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
As of Fiscal Year 2013
Dr. Laurence E. Reid, Ph.D., has been Chief Business Officer and Senior Vice President at Alnylam Pharmaceuticals, Inc. since June 2010. Dr. Reid served as Chief Business Officer at Ensemble Therapeutics Corporation(also known as Ensemble Discovery Corporation) since March 2006 and served as its Head of Business Development and Corporate Development. Dr. Reid has over 20 years of diverse business and science experience in the life sciences field. His experience includes ...
300 Third StreetPhone: 617-551-8200
Cambridge, Massachusetts 02142
Board Members Memberships*There is no Board Members Memberships data available.
University of Cambridge
University Of London
|Ali Mortazavi||Chief Executive and Director|
Silence Therapeutics plc
|Hans G. C. P. Schikan||Chief Executive Officer and Member of Management Board|
Prosensa Holding N.V.
|Mark W. Schwartz Ph.D.||Chief Executive Officer and President|
Galena Biopharma, Inc.
|Mark J. Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|Kleanthis G. Xanthopoulos Ph.D.||Chief Executive Officer, President, Principal Financial & Accounting Officer and Director|
Regulus Therapeutics Inc.
|$600.0K||Compensation as of Fiscal Year 2013.|